Jiangxi Puzhuo Medical Equipment Co., Ltd

Plain and Simple News Flash | Medical Insurance Prices in Multiple Regions Have Been Updated! A Comprehensive Perspective on Magnetic and Electrical Stimulation Therapy Charges and Medical Insurance Policies. Plain and Simple Medical Insight into Medical

Publication Date:2026-03-25 visits:9 View original text

640 (3)


For departments carrying out neuromodulation technologies such as Transcranial Magnetic Stimulation (TMS) and Transcranial Electrical Stimulation (TES), project pricing and medical insurance classification directly affect the popularization and sustainable development of these technologies. In accordance with the Guidelines for Project Initiation of Nervous‑System‑Related Medical Service Prices (Trial) issued by the National Healthcare Security Administration in 2026, provincial healthcare security bureaus have successively launched the bundled charge item of "Non‑invasive Nerve Stimulation Therapy Fee", gradually replacing the original independent charge items such as "Transcranial Magnetic Stimulation Therapy" and "Transcranial Electrical Stimulation Therapy".

Taking Inner Mongolia Autonomous Region as an example, in compliance with Document No. 〔2025〕90 of Inner Mongolia Healthcare Security Office, Notice on Regulating Medical Service Price Items for the Nervous System, the new policy has been implemented since September 2025. It comprehensively integrates medical service items for the nervous system, brings non‑invasive nerve stimulation technologies including transcranial magnetic stimulation and transcranial electrical stimulation under unified charging management, and phases out the original independent charge items. Hohhot has taken the lead in local implementation.

The period from late 2025 to the first half of 2026 witnesses the concentrated implementation of a new round of national price policies. This trend sends a clear signal: non‑invasive neuromodulation technologies are being rapidly and systematically brought under standardized management by local healthcare security and price regulatory authorities.


"Non‑invasive Nerve Stimulation Therapy Fee" refers to the treatment of neuropsychiatric diseases and functional disorders by applying non‑invasive physical energy such as transcranial magnetic and transcranial electrical stimulation to relevant parts of the nervous system, so as to modulate neural electrical activity and brain network functions.

Timetables are critical for policy implementation. We have sorted out key regions and items with confirmed new‑price execution in 2026 for your quick reference. If your region is included, it is recommended that you pay close attention to the specific effective date and complete in‑hospital coordination and business preparation in advance.


640 (4)

Of course, reform cannot be accomplished overnight. While the unified new item (i.e. "Non‑invasive Nerve Stimulation Therapy Fee") is being gradually rolled out, quite a number of regions across the country still maintain the original diversified independent‑item charging modes for magnetic / electrical stimulation and related therapies. Understanding these modes is equally important for grasping the overall market landscape. Let us first look at transcranial magnetic stimulation.

640 (5)

After reviewing transcranial magnetic stimulation, let us move on to transcranial electrical stimulation. Similar to magnetic stimulation, electrical stimulation is being incorporated into "Non‑invasive Nerve Stimulation Therapy Fee" in most regions, while independent "Electrical Stimulation Therapy Fee" items still exist.

640 (6)

Apart from core magnetic and electrical stimulation, closely‑related items such as brain reflex therapy and electroencephalogram therapy are often updated together in local charging systems. Their prices and medical‑insurance categories are non‑negligible factors for departments in project portfolio design and cost accounting.

640 (7)

The above summary is based on public bidding and procurement documents available as of early 2026. Actual implementation shall be subject to the final notice issued by local medical‑insurance authorities. Have the new prices been put into effect in your region? What problems have you encountered in practical operations? You are welcome to leave comments for sharing, or send us private messages for communication and discussion. Bookmark this article for easy access at any time!